Cancer stem cell characteristics of circulating tumor cells (Q38181528)

30 August 2017

title

Cancer stem cell characteristics of circulating tumor cells (English)

1 reference

30 August 2017

main subject

neoplastic stem cells

1 reference

Ingeborg Tinhofer

1

1 reference

30 August 2017

Mohammad Saki

2

1 reference

30 August 2017

Franlziska Niehr

3

1 reference

30 August 2017

Ulrich Keilholz

4

1 reference

30 August 2017

Volker Budach

5

1 reference

30 August 2017

publication date

12 May 2014

1 reference

International Journal of Radiation Biology

30 August 2017

published in

1 reference

30 August 2017

volume

90

1 reference

30 August 2017

issue

8

1 reference

30 August 2017

page(s)

622-627

1 reference

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Lack of radiation dose or quality dependence of epithelial-to-mesenchymal transition (EMT) mediated by transforming growth factor β.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Cancer stem cells: a step toward the cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

A perspective on cancer cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating tumor cells as biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Tumour-cell invasion and migration: diversity and escape mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Mobilization of viable tumor cells into the circulation during radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Protons sensitize epithelial cells to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.886798

10.3109/09553002.2014.886798

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference